Kristin Cirello Pothier
Principal and U.S. and Americas life sciences sector leader and global deal advisory and strategy leader for health and life sciences at KPMG, advising on M&A, deal strategy, and industry outlooks.
Best podcasts with Kristin Cirello Pothier
Ranked by the Snipd community
11 snips
Jan 30, 2026 • 22min
Biopharma's rebound keeping pace so far
Kristin Cirello Pothier, KPMG life sciences and global deal strategy leader, discusses the 2026 investment outlook. She reviews 2025 deal lessons, why cost discipline rose after COVID, and which early‑2026 acquisitions signal priorities. Conversations cover FDA uncertainty, manufacturing choices for smaller firms, and how valuations favor proven innovation.
